Foresee Pharmaceuticals Co., Ltd.
6576
Rank in Stocks
#14032
Foresee is a Taiwan and US-based biopharmaceutical company focused on two key... Foresee is a Taiwan and US-based biopharmaceutical company focused on two key areas: its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products for specialty markets, and its transformative preclinical and clinical first-in-class New Chemical Entity (NCE) programs targeting rare and severe disease areas with high unmet needs. Its product portfolio includes late and early-stage programs, with its lead product CAMCEVI® used for the treatment of advanced prostate cancer.
Share Price
$2.22
Last synced: 2026-11-10
Market Cap
$349.14M
Change (1 day)
-1.62%
Change (1 year)
-10.09%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Foresee Pharmaceuticals Co., Ltd. (6576)
Category
Healthcare
Operating Margin for Foresee Pharmaceuticals Co., Ltd. (6576)
Operating Margin as of November 2026 TTM: -104.50%
According to Foresee Pharmaceuticals Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -104.50%. At the end of 2025 the company had an operating margin of -199.95%.
Operating Margin history for Foresee Pharmaceuticals Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -104.50% | -47.74% |
| 2025 | -199.95% | -22.47% |
| 2024 | -257.90% | -50.08% |
| 2023 | -516.63% | 255.85% |
| 2022 | -145.18% | -37.77% |
| 2021 | -233.29% | 11.57% |
| 2020 | -209.09% | -66.56% |
| 2019 | -625.18% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -100.60% |
US
|
|
| 31.60% | -100.30% |
SE
|
|
| 30.13% | -100.29% |
FR
|
|
| 29.76% | -100.28% |
HK
|
|
| 30.46% | -100.29% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Foresee Pharmaceuticals Co., Ltd.'s operating margin
What is Foresee Pharmaceuticals Co., Ltd.'s operating margin?
Foresee Pharmaceuticals Co., Ltd.'s operating margin is -104.50%, as of Nov 2026.
What was Foresee Pharmaceuticals Co., Ltd.'s operating margin in 2025?
In 2025, Foresee Pharmaceuticals Co., Ltd.'s operating margin was -199.95%, compared with -257.90% in 2024.
How has Foresee Pharmaceuticals Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Foresee Pharmaceuticals Co., Ltd.'s operating margin was highest in 2022 (-145.18%) and lowest in 2023 (-516.63%).
How does Foresee Pharmaceuticals Co., Ltd.'s operating margin compare with similar companies?
Foresee Pharmaceuticals Co., Ltd.'s operating margin (-104.50%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.